Product
ZH9
1 clinical trial
3 indications
Indication
NMIBCIndication
Non-Muscle-Invasive Bladder CancerClinical trial
A Phase 1/1b Study Evaluating the Safety, Pharmacology, and Clinical Effect of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder CancerStatus: Recruiting, Estimated PCD: 2025-02-03